Record Information |
---|
Version | 5.0 |
---|
Status | Expected but not Quantified |
---|
Creation Date | 2012-09-06 15:16:49 UTC |
---|
Update Date | 2022-03-07 02:51:37 UTC |
---|
HMDB ID | HMDB0014442 |
---|
Secondary Accession Numbers | |
---|
Metabolite Identification |
---|
Common Name | Bupivacaine |
---|
Description | Bupivacaine is only found in individuals that have used or taken this drug. It is a widely used local anesthetic agent. [PubChem]Bupivacaine blocks the generation and the conduction of nerve impulses, presumably by increasing the threshold for electrical excitation in the nerve, by slowing the propagation of the nerve impulse, and by reducing the rate of rise of the action potential. Bupivacaine binds to the intracellular portion of sodium channels and blocks sodium influx into nerve cells, which prevents depolarization. In general, the progression of anesthesia is related to the diameter, myelination and conduction velocity of affected nerve fibers. Clinically, the order of loss of nerve function is as follows: (1) pain, (2) temperature, (3) touch, (4) proprioception, and (5) skeletal muscle tone. The analgesic effects of Bupivicaine are thought to potentially be due to its binding to the prostaglandin E2 receptors, subtype EP1 (PGE2EP1), which inhibits the production of prostaglandins, thereby reducing fever, inflammation, and hyperalgesia. |
---|
Structure | CCCCN1CCCCC1C(=O)NC1=C(C)C=CC=C1C InChI=1S/C18H28N2O/c1-4-5-12-20-13-7-6-11-16(20)18(21)19-17-14(2)9-8-10-15(17)3/h8-10,16H,4-7,11-13H2,1-3H3,(H,19,21) |
---|
Synonyms | Value | Source |
---|
Bupivacaina | ChEBI | Bupivacainum | ChEBI | DL-Bupivacaine | ChEBI | Marcaine | ChEBI | Bucaine | Kegg | Exparel | Kegg | (+-)-Bupivacaine | HMDB | Bloqueina | HMDB | Bupivacaine HCL | HMDB | Bupivacaine HCL kit | HMDB | CBupivacaine | HMDB | DUR-843 | HMDB | LAC-43 | HMDB | Braun, bupivacaina | MeSH, HMDB | Bupivacaine carbonate | MeSH, HMDB | Bupivacaine monohydrochloride, monohydrate | MeSH, HMDB | Strathmann brand OF bupivacaine hydrochloride | MeSH, HMDB | Abbott brand OF bupivacaine hydrochloride | MeSH, HMDB | Astra brand OF bupivacaine hydrochloride | MeSH, HMDB | Carbostesin | MeSH, HMDB | Dolanaest | MeSH, HMDB | Inibsa brand OF bupivacaine hydrochloride | MeSH, HMDB | Janapharm, bupivacain | MeSH, HMDB | 1-Butyl-N-(2,6-dimethylphenyl)-2-piperidinecarboxamide | MeSH, HMDB | Anhydrous, bupivacaine | MeSH, HMDB | Bupivacain janapharm | MeSH, HMDB | Bupivacain-RPR | MeSH, HMDB | Bupivacaina braun | MeSH, HMDB | Bupivacaine anhydrous | MeSH, HMDB | Bupivacaine hydrochloride | MeSH, HMDB | Carbonate, bupivacaine | MeSH, HMDB | Jenapharm brand OF bupivacaine hydrochloride | MeSH, HMDB | Sensorcaine | MeSH, HMDB | AstraZeneca brand OF bupivacaine hydrochloride | MeSH, HMDB | Aventis brand OF bupivacaine hydrochloride | MeSH, HMDB | Braun brand OF bupivacaine hydrochloride | MeSH, HMDB | Bupivacain RPR | MeSH, HMDB | Buvacaina | MeSH, HMDB | Hydrochloride, bupivacaine | MeSH, HMDB | Marcain | MeSH, HMDB | Pisa brand OF bupivacaine hydrochloride | MeSH, HMDB | Svedocain sin vasoconstr | MeSH, HMDB |
|
---|
Chemical Formula | C18H28N2O |
---|
Average Molecular Weight | 288.4277 |
---|
Monoisotopic Molecular Weight | 288.220163528 |
---|
IUPAC Name | 1-butyl-N-(2,6-dimethylphenyl)piperidine-2-carboxamide |
---|
Traditional Name | bupivacaine |
---|
CAS Registry Number | 2180-92-9 |
---|
SMILES | CCCCN1CCCCC1C(=O)NC1=C(C)C=CC=C1C |
---|
InChI Identifier | InChI=1S/C18H28N2O/c1-4-5-12-20-13-7-6-11-16(20)18(21)19-17-14(2)9-8-10-15(17)3/h8-10,16H,4-7,11-13H2,1-3H3,(H,19,21) |
---|
InChI Key | LEBVLXFERQHONN-UHFFFAOYSA-N |
---|
Chemical Taxonomy |
---|
Description | Belongs to the class of organic compounds known as alpha amino acid amides. These are amide derivatives of alpha amino acids. |
---|
Kingdom | Organic compounds |
---|
Super Class | Organic acids and derivatives |
---|
Class | Carboxylic acids and derivatives |
---|
Sub Class | Amino acids, peptides, and analogues |
---|
Direct Parent | Alpha amino acid amides |
---|
Alternative Parents | |
---|
Substituents | - Alpha-amino acid amide
- 2-piperidinecarboxamide
- Piperidinecarboxamide
- Anilide
- M-xylene
- Xylene
- N-arylamide
- Monocyclic benzene moiety
- Benzenoid
- Piperidine
- Carboxamide group
- Tertiary aliphatic amine
- Tertiary amine
- Secondary carboxylic acid amide
- Azacycle
- Organoheterocyclic compound
- Organic nitrogen compound
- Hydrocarbon derivative
- Organic oxide
- Organooxygen compound
- Organonitrogen compound
- Organopnictogen compound
- Carbonyl group
- Organic oxygen compound
- Amine
- Aromatic heteromonocyclic compound
|
---|
Molecular Framework | Aromatic heteromonocyclic compounds |
---|
External Descriptors | |
---|
Ontology |
---|
Physiological effect | Not Available |
---|
Disposition | |
---|
Process | Not Available |
---|
Role | Not Available |
---|
Physical Properties |
---|
State | Solid |
---|
Experimental Molecular Properties | Property | Value | Reference |
---|
Melting Point | 107 - 108 °C | Not Available | Boiling Point | Not Available | Not Available | Water Solubility | 0.098 g/L | Not Available | LogP | 3.6 | Not Available |
|
---|
Experimental Chromatographic Properties | Experimental Collision Cross Sections |
---|
Predicted Molecular Properties | |
---|
Predicted Chromatographic Properties | Predicted Collision Cross SectionsPredicted Kovats Retention IndicesUnderivatizedDerivatizedDerivative Name / Structure | SMILES | Kovats RI Value | Column Type | Reference |
---|
Bupivacaine,1TMS,isomer #1 | CCCCN1CCCCC1C(=O)N(C1=C(C)C=CC=C1C)[Si](C)(C)C | 2163.0 | Semi standard non polar | 33892256 | Bupivacaine,1TMS,isomer #1 | CCCCN1CCCCC1C(=O)N(C1=C(C)C=CC=C1C)[Si](C)(C)C | 2224.1 | Standard non polar | 33892256 | Bupivacaine,1TMS,isomer #1 | CCCCN1CCCCC1C(=O)N(C1=C(C)C=CC=C1C)[Si](C)(C)C | 2862.7 | Standard polar | 33892256 | Bupivacaine,1TBDMS,isomer #1 | CCCCN1CCCCC1C(=O)N(C1=C(C)C=CC=C1C)[Si](C)(C)C(C)(C)C | 2383.9 | Semi standard non polar | 33892256 | Bupivacaine,1TBDMS,isomer #1 | CCCCN1CCCCC1C(=O)N(C1=C(C)C=CC=C1C)[Si](C)(C)C(C)(C)C | 2453.3 | Standard non polar | 33892256 | Bupivacaine,1TBDMS,isomer #1 | CCCCN1CCCCC1C(=O)N(C1=C(C)C=CC=C1C)[Si](C)(C)C(C)(C)C | 2963.4 | Standard polar | 33892256 |
|
---|
| GC-MS SpectraSpectrum Type | Description | Splash Key | Deposition Date | Source | View |
---|
Predicted GC-MS | Predicted GC-MS Spectrum - Bupivacaine GC-MS (Non-derivatized) - 70eV, Positive | splash10-006t-6920000000-20e4e8d5c09a52a31c75 | 2017-09-01 | Wishart Lab | View Spectrum | Predicted GC-MS | Predicted GC-MS Spectrum - Bupivacaine GC-MS (Non-derivatized) - 70eV, Positive | Not Available | 2021-10-12 | Wishart Lab | View Spectrum | Predicted GC-MS | Predicted GC-MS Spectrum - Bupivacaine GC-MS (Non-derivatized) - 70eV, Positive | Not Available | 2021-10-12 | Wishart Lab | View Spectrum |
MS/MS SpectraSpectrum Type | Description | Splash Key | Deposition Date | Source | View |
---|
Experimental LC-MS/MS | LC-MS/MS Spectrum - Bupivacaine LC-ESI-QFT , positive-QTOF | splash10-000i-0290000000-c1dbebb634be5e7e1140 | 2017-09-14 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - Bupivacaine LC-ESI-QFT , positive-QTOF | splash10-0006-0910000000-ae34de204bcb9a9deb23 | 2017-09-14 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - Bupivacaine LC-ESI-QFT , positive-QTOF | splash10-0006-0900000000-7ea7001506aae0c271a0 | 2017-09-14 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - Bupivacaine LC-ESI-QFT , positive-QTOF | splash10-0006-2900000000-ef819c5e235d6d524d8c | 2017-09-14 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - Bupivacaine LC-ESI-QFT , positive-QTOF | splash10-0006-7900000000-22d7491053c05d773e93 | 2017-09-14 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - Bupivacaine LC-ESI-QFT , positive-QTOF | splash10-001l-9400000000-71357b8186126c5933ce | 2017-09-14 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - Bupivacaine 90V, Positive-QTOF | splash10-001l-9400000000-f152216f702642a2a96b | 2021-09-20 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - Bupivacaine 15V, Positive-QTOF | splash10-000i-0290000000-473772a88887df5462f7 | 2021-09-20 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - Bupivacaine 45V, Positive-QTOF | splash10-0006-0900000000-73c58abee6a70ae243ed | 2021-09-20 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - Bupivacaine 30V, Positive-QTOF | splash10-0006-0910000000-2d35aaa0fbbc69b60c7d | 2021-09-20 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - Bupivacaine 60V, Positive-QTOF | splash10-0006-2900000000-c1144b59f68c25239771 | 2021-09-20 | HMDB team, MONA | View Spectrum | Experimental LC-MS/MS | LC-MS/MS Spectrum - Bupivacaine 75V, Positive-QTOF | splash10-0006-7900000000-a4b8408dc9df27267589 | 2021-09-20 | HMDB team, MONA | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Bupivacaine 10V, Positive-QTOF | splash10-0079-0970000000-e665f05dc8da9fafd8f0 | 2016-08-03 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Bupivacaine 20V, Positive-QTOF | splash10-00dl-2900000000-6396ddc6fc9d5e9b6c64 | 2016-08-03 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Bupivacaine 40V, Positive-QTOF | splash10-0ac0-9200000000-befeaee90e72918d68b3 | 2016-08-03 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Bupivacaine 10V, Negative-QTOF | splash10-000i-0290000000-e01610a30f93d9c5ec2a | 2016-08-03 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Bupivacaine 20V, Negative-QTOF | splash10-00ri-0970000000-e26949f880557c6da815 | 2016-08-03 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Bupivacaine 40V, Negative-QTOF | splash10-00xr-3900000000-56dfe5d9cd7f629f17e3 | 2016-08-03 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Bupivacaine 10V, Negative-QTOF | splash10-000i-0090000000-e83ab5b70775090159b7 | 2021-09-25 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Bupivacaine 20V, Negative-QTOF | splash10-000i-0690000000-6ff0193988455d286726 | 2021-09-25 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Bupivacaine 40V, Negative-QTOF | splash10-00xr-1920000000-87f1897c4a60793791d5 | 2021-09-25 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Bupivacaine 10V, Positive-QTOF | splash10-000i-0190000000-23ffc562239624515183 | 2021-09-25 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Bupivacaine 20V, Positive-QTOF | splash10-000g-3920000000-6aaf7d8f5f0149cec33e | 2021-09-25 | Wishart Lab | View Spectrum | Predicted LC-MS/MS | Predicted LC-MS/MS Spectrum - Bupivacaine 40V, Positive-QTOF | splash10-0007-8900000000-e62af4b8065c6c1caf01 | 2021-09-25 | Wishart Lab | View Spectrum |
|
---|